FOSAPREPITANT DIMEGLUMINE

FOSAPREPITANT DIMEGLUMINE was reported 13816 times

FOSAPREPITANT DIMEGLUMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 118 0.5153
1 TESTICULAR GERM CELL CANCER METASTATIC 13 0.4815
2 COMPUTERISED TOMOGRAM THORAX 23 0.3833
3 SWOLLEN JOINT COUNT 77 0.3080
4 INJECTION SITE VASCULITIS 12 0.2105
5 INFUSION SITE STREAKING 15 0.1724
6 PROCALCITONIN DECREASED 12 0.1714
7 ACQUIRED PORPHYRIA 11 0.1549
8 LUPUS VULGARIS 170 0.1349
9 PULMONARY SEPTAL THICKENING 12 0.1348
10 PORPHYRIA ACUTE 165 0.1150
11 INJECTION SITE PHLEBITIS 26 0.1111
12 X-RAY ABNORMAL 192 0.1073
13 DEEP VEIN THROMBOSIS POSTOPERATIVE 208 0.1038
14 C-REACTIVE PROTEIN 93 0.1003
15 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 67 0.1003
16 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 193 0.0931
17 NAIL BED INFLAMMATION 29 0.0909
18 RETINITIS 156 0.0902
19 DISLOCATION OF VERTEBRA 196 0.0859
20 FACET JOINT SYNDROME 257 0.0789
21 DUODENAL ULCER PERFORATION 569 0.0764
22 TONSILLAR HAEMORRHAGE 11 0.0753
23 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 483 0.0743
24 SWOLLEN JOINT COUNT INCREASED 231 0.0724
25 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 503 0.0701
26 COMPUTERISED TOMOGRAM THORAX ABNORMAL 43 0.0626
27 RHEUMATIC FEVER 275 0.0616
28 IMMUNOTOXICITY 7 0.0614
29 EOSINOPHIL PERCENTAGE DECREASED 12 0.0603
30 MUSCLE INJURY 495 0.0597
31 COLONY STIMULATING FACTOR THERAPY 12 0.0580
32 SEMINOMA 13 0.0546
33 FOLLICULITIS 572 0.0545
34 HELICOBACTER INFECTION 559 0.0543
35 RHEUMATOID FACTOR POSITIVE 295 0.0510
36 BONE EROSION 167 0.0472
37 NASAL MUCOSAL DISORDER 27 0.0463
38 ANTIPHOSPHOLIPID ANTIBODIES 9 0.0462
39 ANTINUCLEAR ANTIBODY 7 0.0443
40 PERIPHERAL VENOUS DISEASE 178 0.0435
41 HAND DEFORMITY 567 0.0432
42 BLOOD CREATINE DECREASED 13 0.0430
43 C-REACTIVE PROTEIN ABNORMAL 276 0.0430
44 PEMPHIGUS 474 0.0379
45 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 21 0.0374
46 BREAST CANCER STAGE III 221 0.0341
47 DRUG TOLERANCE DECREASED 95 0.0338
48 APLASIA 59 0.0301
49 ENTEROBACTER BACTERAEMIA 9 0.0297
50 INTERCEPTED DRUG ADMINISTRATION ERROR 13 0.0296
51 MATERNAL EXPOSURE TIMING UNSPECIFIED 110 0.0293
52 PERICARDITIS 492 0.0293
53 CULTURE STOOL POSITIVE 8 0.0292
54 SYNOVITIS 522 0.0289
55 STREPTOCOCCAL SEPSIS 34 0.0287
56 LIP DRY 253 0.0278
57 DENTAL FISTULA 11 0.0264
58 GLOSSODYNIA 581 0.0259
59 FEBRILE BONE MARROW APLASIA 105 0.0247
60 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 11 0.0240
61 IRRITABLE BOWEL SYNDROME 512 0.0239
62 SENSE OF OPPRESSION 27 0.0229
63 HYPOCHOLESTEROLAEMIA 8 0.0227
64 AUTOIMMUNE DISORDER 221 0.0227
65 AORTIC VALVE CALCIFICATION 11 0.0214
66 JOINT RANGE OF MOTION DECREASED 279 0.0208
67 WOUND INFECTION 220 0.0201
68 PSEUDOMONAL SEPSIS 34 0.0194
69 NEUTROPENIC COLITIS 40 0.0193
70 BURSITIS 227 0.0187
71 GRIP STRENGTH DECREASED 164 0.0186
72 WOUND 518 0.0185
73 LUPUS-LIKE SYNDROME 168 0.0185
74 C-REACTIVE PROTEIN DECREASED 12 0.0184
75 ALOPECIA TOTALIS 6 0.0182
76 HYPERCHOLESTEROLAEMIA 176 0.0182
77 IMPAIRED HEALING 590 0.0180
78 BLOOD FOLATE DECREASED 13 0.0179
79 EXOSTOSIS 162 0.0177
80 SYSTEMIC LUPUS ERYTHEMATOSUS 566 0.0159
81 SERONEGATIVE ARTHRITIS 18 0.0157
82 LIVE BIRTH 123 0.0147
83 HYPOCHLORAEMIA 17 0.0145
84 SCIATICA 229 0.0144
85 HYPERBILIRUBINAEMIA NEONATAL 8 0.0137
86 KLEBSIELLA BACTERAEMIA 13 0.0137
87 HAIR DISORDER 112 0.0136
88 WALKING AID USER 89 0.0135
89 SARS-COV-2 TEST NEGATIVE 9 0.0133
90 CONTRAINDICATED PRODUCT ADMINISTERED 403 0.0133
91 VASCULAR DEVICE INFECTION 60 0.0132
92 FOOT DEFORMITY 144 0.0130
93 LARYNGEAL DISCOMFORT 8 0.0126
94 ALOPECIA AREATA 22 0.0125
95 FEBRILE NEUTROPENIA 827 0.0125
96 TUMOUR PAIN 16 0.0121
97 BLOOD UREA DECREASED 15 0.0121
98 CATHETER SITE RELATED REACTION 9 0.0120
99 STOMATITIS 713 0.0117
100 LOWER LIMB FRACTURE 225 0.0117
101 INFUSION RELATED HYPERSENSITIVITY REACTION 7 0.0116
102 INFUSION RELATED REACTION 772 0.0116
103 PULMONARY FIBROSIS 223 0.0116
104 FIBROMYALGIA 282 0.0116
105 LOWER RESPIRATORY TRACT INFECTION 520 0.0114
106 HAIR COLOUR CHANGES 134 0.0108
107 OBESITY 171 0.0107
108 PALMAR ERYTHEMA 12 0.0104
109 INTESTINAL PSEUDO-OBSTRUCTION 9 0.0102
110 LEFT ATRIAL DILATATION 13 0.0102
111 STREPTOCOCCAL BACTERAEMIA 11 0.0101
112 MADAROSIS 117 0.0101
113 HAIR TEXTURE ABNORMAL 134 0.0100
114 FIXED ERUPTION 17 0.0099
115 HICCUPS 81 0.0099
116 BLISTER 541 0.0096
117 PSYCHOLOGICAL TRAUMA 83 0.0096
118 HEPATOCELLULAR INJURY 134 0.0094
119 COMA HEPATIC 7 0.0094
120 HEPATIC CIRRHOSIS 175 0.0093
121 EYE INJURY 28 0.0092
122 ARTHROPATHY 511 0.0092
123 HEPATIC ENZYME INCREASED 625 0.0092
124 ILL-DEFINED DISORDER 550 0.0090
125 RED BLOOD CELL SEDIMENTATION RATE INCREASED 100 0.0090
126 DISCOMFORT 544 0.0089
127 PARONYCHIA 39 0.0089
128 CARBON DIOXIDE DECREASED 10 0.0087
129 INFUSION SITE IRRITATION 11 0.0086
130 WEIGHT FLUCTUATION 89 0.0085
131 EOSINOPHIL COUNT DECREASED 20 0.0084
132 LIVER INJURY 206 0.0084
133 ATELECTASIS 80 0.0083
134 JOINT DISLOCATION 87 0.0082
135 TYPE 2 DIABETES MELLITUS 276 0.0082
136 HYPERAMMONAEMIC ENCEPHALOPATHY 14 0.0080
137 THROMBOCYTOPENIC PURPURA 11 0.0080
138 PHARYNGEAL ERYTHEMA 17 0.0080
139 PRESCRIBED OVERDOSE 155 0.0080
140 ABDOMINAL SEPSIS 7 0.0079
141 CYTOLYTIC HEPATITIS 26 0.0078
142 ALVEOLITIS 11 0.0078
143 RADIATION SKIN INJURY 9 0.0078
144 BLOOD CHLORIDE DECREASED 20 0.0077
145 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 131 0.0077
146 PREGNANCY 154 0.0077
147 ENTEROCOLITIS INFECTIOUS 7 0.0076
148 ANORECTAL DISORDER 15 0.0075
149 NIGHT SWEATS 242 0.0075
150 MUCOSAL INFLAMMATION 195 0.0074
151 ENCEPHALOPATHY 182 0.0074
152 ENTERITIS 47 0.0073
153 CEREBELLAR SYNDROME 16 0.0073
154 DIABETIC METABOLIC DECOMPENSATION 10 0.0072
155 BICYTOPENIA 14 0.0071
156 SOFT TISSUE INFECTION 13 0.0071
157 TONIC CONVULSION 10 0.0071
158 LIVER DISORDER 313 0.0071
159 SUBCLAVIAN VEIN THROMBOSIS 8 0.0070
160 POST HERPETIC NEURALGIA 10 0.0070
161 TONGUE COATED 12 0.0069
162 CLONUS 19 0.0069
163 PROTEIN TOTAL DECREASED 26 0.0069
164 GASTROINTESTINAL DISORDER 607 0.0068
165 ROAD TRAFFIC ACCIDENT 283 0.0068
166 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 12 0.0067
167 APLASTIC ANAEMIA 35 0.0067
168 BONE MARROW FAILURE 135 0.0066
169 ASPARTATE AMINOTRANSFERASE ABNORMAL 10 0.0066
170 DELIRIUM 227 0.0065
171 BODY TEMPERATURE ABNORMAL 12 0.0065
172 INJURY 458 0.0065
173 OTOTOXICITY 12 0.0065
174 FREQUENT BOWEL MOVEMENTS 172 0.0064
175 NEUTROPHIL COUNT DECREASED 259 0.0063
176 HIP ARTHROPLASTY 97 0.0063
177 SLEEP DISORDER 440 0.0062
178 PSORIATIC ARTHROPATHY 253 0.0062
179 IMMUNE-MEDIATED HYPOTHYROIDISM 7 0.0062
180 TONIC CLONIC MOVEMENTS 8 0.0061
181 TOXIC ENCEPHALOPATHY 31 0.0061
182 PELVIC ABSCESS 7 0.0061
183 INFUSION SITE REACTION 18 0.0060
184 CATHETER RELATED INFECTION 6 0.0059
185 SEDATION COMPLICATION 15 0.0059
186 MAGNETIC RESONANCE IMAGING ABNORMAL 7 0.0059
187 GENERAL PHYSICAL HEALTH DETERIORATION 673 0.0058
188 FLUID INTAKE REDUCED 29 0.0058
189 JOINT DESTRUCTION 9 0.0058
190 AXILLARY MASS 6 0.0058
191 SWELLING 535 0.0057
192 CONTUSION 550 0.0057
193 THROMBOPHLEBITIS 20 0.0057
194 EAR INFECTION 150 0.0056
195 METASTASES TO LYMPH NODES 38 0.0056
196 VARICOSE VEIN 29 0.0056
197 KERATITIS 17 0.0056
198 BLEPHAROSPASM 35 0.0056
199 LUNG DISORDER 272 0.0055
200 RED CELL DISTRIBUTION WIDTH INCREASED 23 0.0055
201 OXYGEN THERAPY 9 0.0055
202 WHEEZING 323 0.0054
203 HYPERAMMONAEMIA 27 0.0054
204 THERAPEUTIC PRODUCT EFFECT DECREASED 241 0.0054
205 ENTEROCOLITIS 31 0.0054
206 MALIGNANT PLEURAL EFFUSION 9 0.0053
207 VENOUS THROMBOSIS LIMB 11 0.0053
208 PRESCRIBED UNDERDOSE 106 0.0053
209 CONGENITAL ANOMALY 41 0.0053
210 SINUSITIS 542 0.0053
211 INTESTINAL ISCHAEMIA 29 0.0053
212 C-REACTIVE PROTEIN INCREASED 191 0.0052
213 PUSTULAR PSORIASIS 18 0.0052
214 STAPHYLOCOCCUS TEST POSITIVE 11 0.0052
215 INFLAMMATION 269 0.0052
216 LARYNGOSPASM 14 0.0052
217 AORTIC THROMBOSIS 6 0.0052
218 VULVOVAGINAL CANDIDIASIS 7 0.0052
219 ALLODYNIA 6 0.0051
220 MUCOUS MEMBRANE DISORDER 7 0.0051
221 OSTEOARTHRITIS 217 0.0051
222 ANAPHYLACTOID REACTION 21 0.0051
223 PHLEBITIS 26 0.0051
224 BONE MARROW TOXICITY 6 0.0051
225 HYPOKALAEMIA 233 0.0050
226 LARGE INTESTINE PERFORATION 35 0.0050
227 CHEMOTHERAPY 19 0.0050
228 HYPOALBUMINAEMIA 39 0.0050
229 PERIPHERAL MOTOR NEUROPATHY 7 0.0050
230 WHITE BLOOD CELL COUNT INCREASED 191 0.0050
231 HYPERTHERMIA 38 0.0050
232 BLOOD CHOLESTEROL INCREASED 232 0.0050
233 COLON CANCER METASTATIC 8 0.0050
234 ANAPHYLACTIC SHOCK 128 0.0050
235 RASH MACULO-PAPULAR 110 0.0049
236 DERMATITIS ACNEIFORM 30 0.0049
237 MUSCULOSKELETAL PAIN 254 0.0048
238 HYPOMAGNESAEMIA 67 0.0048
239 GASTROINTESTINAL NECROSIS 14 0.0048
240 FEELING HOT 292 0.0048
241 OEDEMA 258 0.0048
242 GENERALISED ERYTHEMA 27 0.0047
243 RECTAL HAEMORRHAGE 202 0.0047
244 SPONDYLITIS 17 0.0047
245 HYPERSENSITIVITY 861 0.0046
246 ALOPECIA 906 0.0046
247 RHEUMATOID ARTHRITIS 521 0.0046
248 RASH VESICULAR 22 0.0045
249 TUMOUR LYSIS SYNDROME 40 0.0045
250 BLOOD ALBUMIN DECREASED 36 0.0045
251 INFUSION SITE PAIN 58 0.0045
252 METASTASES TO CENTRAL NERVOUS SYSTEM 58 0.0045
253 OESOPHAGITIS 49 0.0045
254 HYPOPHOSPHATAEMIA 33 0.0045
255 INFECTION 639 0.0044
256 VENOOCCLUSIVE DISEASE 11 0.0044
257 EXTRAVASATION 18 0.0044
258 STAPHYLOCOCCAL BACTERAEMIA 19 0.0044
259 GAIT INABILITY 146 0.0044
260 ODYNOPHAGIA 26 0.0044
261 JOINT SWELLING 525 0.0043
262 INTRACRANIAL PRESSURE INCREASED 24 0.0043
263 CRANIOCEREBRAL INJURY 13 0.0043
264 ULCER HAEMORRHAGE 29 0.0043
265 RESPIRATORY DISORDER 127 0.0042
266 COLITIS ULCERATIVE 189 0.0042
267 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 43 0.0042
268 KNEE ARTHROPLASTY 88 0.0042
269 ENTEROBACTER INFECTION 7 0.0042
270 LABORATORY TEST ABNORMAL 122 0.0041
271 FEMALE GENITAL TRACT FISTULA 7 0.0041
272 THROMBOCYTOPENIA 457 0.0041
273 TOXIC SKIN ERUPTION 41 0.0041
274 CONFUSIONAL STATE 657 0.0041
275 JOINT STIFFNESS 106 0.0040
276 HYPOPITUITARISM 7 0.0040
277 AORTIC STENOSIS 14 0.0040
278 ADENOCARCINOMA 9 0.0040
279 PANCREATITIS 212 0.0040
280 BLOOD CULTURE POSITIVE 12 0.0040
281 PANCREATITIS ACUTE 89 0.0040
282 PULMONARY TOXICITY 28 0.0040
283 MOBILITY DECREASED 284 0.0039
284 TONGUE OEDEMA 15 0.0039
285 MATERNAL EXPOSURE DURING PREGNANCY 350 0.0039
286 HYPONATRAEMIA 221 0.0039
287 CANCER PAIN 10 0.0039
288 RENAL TUBULAR DISORDER 11 0.0039
289 NEUTROPHIL COUNT ABNORMAL 11 0.0039
290 ANAPHYLACTIC REACTION 215 0.0039
291 CATHETER SITE PAIN 10 0.0039
292 SUPRAVENTRICULAR EXTRASYSTOLES 13 0.0038
293 GASTROINTESTINAL PERFORATION 16 0.0038
294 BREAST CANCER STAGE II 32 0.0038
295 SUBILEUS 8 0.0038
296 IMMUNE-MEDIATED LUNG DISEASE 7 0.0038
297 LEUKOPENIA 192 0.0038
298 BLOOD PHOSPHORUS DECREASED 14 0.0038
299 TOXIC EPIDERMAL NECROLYSIS 58 0.0038
300 ESCHERICHIA SEPSIS 11 0.0038
301 HYPOXIA 132 0.0037
302 SEPTIC SHOCK 163 0.0037
303 CATHETER SITE ERYTHEMA 8 0.0037
304 CYSTITIS HAEMORRHAGIC 15 0.0037
305 MEDICATION ERROR 206 0.0037
306 INFUSION SITE EXTRAVASATION 23 0.0037
307 PERIPHERAL ISCHAEMIA 15 0.0037
308 CHOLESTASIS 70 0.0036
309 ARTERIAL THROMBOSIS 7 0.0036
310 GASTROINTESTINAL TUBE INSERTION 9 0.0036
311 PERIPHERAL SENSORY NEUROPATHY 21 0.0036
312 BLOOD MAGNESIUM DECREASED 31 0.0036
313 PULSE ABSENT 17 0.0036
314 PYELONEPHRITIS ACUTE 7 0.0036
315 DRY MOUTH 289 0.0036
316 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 83 0.0036
317 EAR PAIN 69 0.0035
318 THROMBOCYTOSIS 13 0.0035
319 ELECTROLYTE IMBALANCE 41 0.0035
320 ABDOMINAL DISCOMFORT 591 0.0035
321 INTERSTITIAL LUNG DISEASE 170 0.0035
322 THERAPY NON-RESPONDER 157 0.0035
323 LUMBAR VERTEBRAL FRACTURE 16 0.0035
324 APHTHOUS ULCER 27 0.0035
325 DISSEMINATED INTRAVASCULAR COAGULATION 49 0.0035
326 OSTEOPOROSIS 142 0.0034
327 IMMUNE-MEDIATED HEPATITIS 7 0.0034
328 TYPE I HYPERSENSITIVITY 12 0.0034
329 STRIDOR 10 0.0034
330 NEUTROPENIA 461 0.0034
331 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 58 0.0034
332 THORACIC VERTEBRAL FRACTURE 10 0.0034
333 PANCYTOPENIA 188 0.0034
334 HAEMOLYTIC ANAEMIA 30 0.0033
335 PYREXIA 1156 0.0033
336 GAMMA-GLUTAMYLTRANSFERASE INCREASED 74 0.0033
337 PERIPHERAL SWELLING 514 0.0033
338 PULSE ABNORMAL 8 0.0033
339 CEREBRAL VENOUS THROMBOSIS 6 0.0033
340 AMNESIA 215 0.0033
341 FLUSHING 335 0.0033
342 HEPATIC CYTOLYSIS 42 0.0033
343 BRAIN OEDEMA 41 0.0032
344 SPINAL FUSION SURGERY 13 0.0032
345 DRUG INTOLERANCE 306 0.0032
346 DERMATITIS EXFOLIATIVE GENERALISED 11 0.0032
347 MUSCULOSKELETAL STIFFNESS 275 0.0031
348 LIPASE INCREASED 24 0.0031
349 VENTRICULAR DYSFUNCTION 8 0.0031
350 METASTASES TO MENINGES 7 0.0031
351 IMMUNE THROMBOCYTOPENIA 14 0.0031
352 ILEUS 38 0.0031
353 VENOOCCLUSIVE LIVER DISEASE 15 0.0030
354 CARDIOTOXICITY 27 0.0030
355 MUSCLE SPASTICITY 37 0.0030
356 PROTEIN TOTAL INCREASED 8 0.0030
357 CYTOKINE RELEASE SYNDROME 60 0.0030
358 PNEUMOCYSTIS JIROVECII PNEUMONIA 30 0.0030
359 HYPERLACTACIDAEMIA 8 0.0030
360 NAIL DISORDER 26 0.0030
361 INFUSION SITE ERYTHEMA 25 0.0030
362 TONGUE ULCERATION 10 0.0030
363 LUNG INFILTRATION 26 0.0029
364 OEDEMA PERIPHERAL 356 0.0029
365 TYPE IV HYPERSENSITIVITY REACTION 8 0.0029
366 HYPOVOLAEMIA 17 0.0029
367 AGRANULOCYTOSIS 54 0.0029
368 CAPILLARY LEAK SYNDROME 6 0.0029
369 MYOSITIS 26 0.0029
370 RASH MORBILLIFORM 8 0.0029
371 NASOPHARYNGITIS 531 0.0029
372 INFUSION SITE SWELLING 18 0.0029
373 EOSINOPHILIC PNEUMONIA 9 0.0029
374 MUSCLE CONTRACTIONS INVOLUNTARY 10 0.0028
375 ABDOMINAL TENDERNESS 14 0.0028
376 IRON DEFICIENCY ANAEMIA 26 0.0028
377 ERYSIPELAS 14 0.0028
378 DERMATITIS BULLOUS 20 0.0028
379 NORMAL NEWBORN 15 0.0028
380 BODY TEMPERATURE INCREASED 56 0.0027
381 WHITE BLOOD CELL COUNT DECREASED 295 0.0027
382 DECREASED APPETITE 632 0.0027
383 IMMUNE-MEDIATED ENTEROCOLITIS 10 0.0027
384 HYPOCALCAEMIA 51 0.0027
385 ADVERSE EVENT 248 0.0027
386 ILEUS PARALYTIC 12 0.0027
387 BLOOD UREA INCREASED 45 0.0027
388 RETINOPATHY 10 0.0027
389 HYPERURICAEMIA 11 0.0027
390 MIXED LIVER INJURY 8 0.0027
391 HEPATITIS CHOLESTATIC 16 0.0027
392 OXYGEN SATURATION DECREASED 149 0.0026
393 ONYCHOMADESIS 11 0.0026
394 TREATMENT FAILURE 217 0.0026
395 DYSAESTHESIA 8 0.0026
396 FUNCTIONAL GASTROINTESTINAL DISORDER 9 0.0026
397 WEIGHT INCREASED 582 0.0026
398 HAEMOLYSIS 20 0.0026
399 ORAL CANDIDIASIS 34 0.0026
400 ABDOMINAL RIGIDITY 7 0.0026
401 PLATELET COUNT DECREASED 274 0.0026
402 RENAL FAILURE ACUTE 109 0.0026
403 JAUNDICE CHOLESTATIC 9 0.0025
404 INJECTION SITE INDURATION 33 0.0025
405 NEONATAL RESPIRATORY DISTRESS SYNDROME 9 0.0025
406 COLITIS 96 0.0025
407 PLATELET COUNT INCREASED 33 0.0025
408 SPUTUM DISCOLOURED 24 0.0025
409 HYPERBILIRUBINAEMIA 26 0.0025
410 ENDOTRACHEAL INTUBATION 7 0.0025
411 FAECES SOFT 18 0.0025
412 DEVICE RELATED INFECTION 38 0.0025
413 PANCREATIC CARCINOMA METASTATIC 7 0.0025
414 TUMOUR HAEMORRHAGE 7 0.0025
415 SMALL FOR DATES BABY 12 0.0024
416 DERMATITIS EXFOLIATIVE 12 0.0024
417 BRONCHOSPASM 34 0.0024
418 JAUNDICE 64 0.0024
419 BLOOD ALKALINE PHOSPHATASE INCREASED 59 0.0024
420 FEEDING DISORDER 48 0.0024
421 DYSPEPSIA 231 0.0023
422 VOMITING 1103 0.0023
423 URTICARIA 389 0.0023
424 PULMONARY ALVEOLAR HAEMORRHAGE 13 0.0023
425 EXPOSURE DURING PREGNANCY 144 0.0023
426 VARICES OESOPHAGEAL 7 0.0023
427 ADRENAL INSUFFICIENCY 28 0.0023
428 TACHYCARDIA 205 0.0023
429 ATRIOVENTRICULAR BLOCK SECOND DEGREE 7 0.0023
430 INTENTIONAL PRODUCT USE ISSUE 202 0.0023
431 IMPAIRED QUALITY OF LIFE 33 0.0023
432 DRUG-INDUCED LIVER INJURY 72 0.0023
433 DYSPNOEA 1297 0.0023
434 PNEUMONITIS 62 0.0023
435 DISABILITY 45 0.0023
436 CHEST PAIN 421 0.0023
437 HYPOTHERMIA 23 0.0023
438 PORTAL HYPERTENSION 7 0.0023
439 GENERAL SYMPTOM 17 0.0023
440 ARTHRITIS 178 0.0023
441 TRANSAMINASES INCREASED 50 0.0022
442 PARAESTHESIA 353 0.0022
443 HYPOAESTHESIA 335 0.0022
444 HYPOPHAGIA 57 0.0022
445 ERYTHEMA 458 0.0022
446 INSOMNIA 591 0.0022
447 RECURRENT CANCER 9 0.0022
448 TRANSFUSION 23 0.0022
449 BACTERAEMIA 26 0.0022
450 EMBOLISM 18 0.0022
451 HYPERTENSION 457 0.0022
452 HYPERTRANSAMINASAEMIA 15 0.0022
453 HYPOVENTILATION 7 0.0021
454 BLOOD BILIRUBIN INCREASED 58 0.0021
455 ORAL PAIN 48 0.0021
456 CACHEXIA 11 0.0021
457 SPINAL PAIN 25 0.0021
458 CANDIDA INFECTION 36 0.0021
459 DEAFNESS NEUROSENSORY 7 0.0021
460 CHOLECYSTITIS ACUTE 12 0.0021
461 INCORRECT DRUG ADMINISTRATION RATE 9 0.0021
462 PLEURAL EFFUSION 128 0.0021
463 POLYNEUROPATHY 25 0.0021
464 ABDOMINAL PAIN 483 0.0021
465 NEOPLASM RECURRENCE 7 0.0021
466 EPILEPSY 63 0.0021
467 EJECTION FRACTION DECREASED 32 0.0021
468 CHEST DISCOMFORT 210 0.0020
469 HYPERTRIGLYCERIDAEMIA 12 0.0020
470 HEPATIC FIBROSIS 7 0.0020
471 RENAL TUBULAR NECROSIS 20 0.0020
472 VULVOVAGINAL MYCOTIC INFECTION 8 0.0020
473 RASH 883 0.0020
474 SINUS HEADACHE 12 0.0020
475 ORGANISING PNEUMONIA 10 0.0020
476 HEPATIC FUNCTION ABNORMAL 75 0.0020
477 ASPIRATION 22 0.0020
478 PRURITUS 770 0.0020
479 ASTHMA 226 0.0020
480 SKIN FISSURES 39 0.0020
481 BLEPHARITIS 8 0.0020
482 PAPILLOEDEMA 9 0.0020
483 OROPHARYNGEAL DISCOMFORT 18 0.0020
484 SUSPECTED OFF LABEL USE 9 0.0020
485 ANAEMIA 379 0.0020
486 NEUROPATHY PERIPHERAL 189 0.0020
487 MUSCULAR WEAKNESS 225 0.0020
488 LYMPHOPENIA 28 0.0020
489 ANURIA 17 0.0020
490 MALNUTRITION 22 0.0020
491 NEUTROPENIC SEPSIS 14 0.0020
492 ACUTE PULMONARY OEDEMA 11 0.0020
493 CHEST X-RAY ABNORMAL 6 0.0020
494 RESPIRATORY SYNCYTIAL VIRUS INFECTION 17 0.0020
495 LOCALISED OEDEMA 9 0.0019
496 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
497 ALTERED STATE OF CONSCIOUSNESS 42 0.0019
498 UNRESPONSIVE TO STIMULI 50 0.0019
499 GENERALISED TONIC-CLONIC SEIZURE 32 0.0019
500 RESPIRATORY DISTRESS 53 0.0019
501 ABDOMINAL PAIN UPPER 395 0.0019
502 TONSILLITIS 10 0.0019
503 CYANOSIS 30 0.0019
504 THROAT TIGHTNESS 51 0.0019
505 NAUSEA 1490 0.0019
506 NON-SMALL CELL LUNG CANCER 9 0.0019
507 GASTROINTESTINAL TOXICITY 9 0.0019
508 INTESTINAL PERFORATION 21 0.0019
509 SINUS BRADYCARDIA 18 0.0019
510 MYOCARDIAL ISCHAEMIA 21 0.0018
511 BACTERIAL SEPSIS 6 0.0018
512 ASCITES 54 0.0018
513 ACUTE KIDNEY INJURY 281 0.0018
514 BREATH SOUNDS ABNORMAL 9 0.0018
515 STAPHYLOCOCCAL SEPSIS 9 0.0018
516 PETECHIAE 19 0.0018
517 LIVER FUNCTION TEST INCREASED 39 0.0018
518 HYPERNATRAEMIA 9 0.0018
519 DRUG ERUPTION 32 0.0018
520 SEPSIS 201 0.0018
521 CARDIAC FAILURE ACUTE 12 0.0018
522 RHINOVIRUS INFECTION 7 0.0018
523 MULTI-ORGAN FAILURE 31 0.0018
524 MIGRAINE 171 0.0018
525 COLITIS ISCHAEMIC 12 0.0018
526 CHOLANGITIS 11 0.0018
527 CLOSTRIDIAL INFECTION 6 0.0018
528 POLYDIPSIA 7 0.0018
529 SKIN TOXICITY 10 0.0018
530 DEHYDRATION 236 0.0018
531 NEUROTOXICITY 31 0.0018
532 PNEUMOTHORAX 28 0.0018
533 PETIT MAL EPILEPSY 9 0.0018
534 SINUS TACHYCARDIA 25 0.0018
535 LYMPHOCYTE COUNT DECREASED 31 0.0018
536 PRODUCT COLOUR ISSUE 9 0.0018
537 APLASIA PURE RED CELL 6 0.0017
538 DIARRHOEA 1125 0.0017
539 RHINITIS 14 0.0017
540 LYMPHOEDEMA 12 0.0017
541 CONDITION AGGRAVATED 527 0.0017
542 TASTE DISORDER 35 0.0017
543 MEMORY IMPAIRMENT 237 0.0017
544 METABOLIC ACIDOSIS 55 0.0017
545 HAEMATOCRIT DECREASED 34 0.0017
546 POLYARTHRITIS 9 0.0017
547 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 82 0.0017
548 METASTASES TO LIVER 30 0.0017
549 SERUM FERRITIN INCREASED 9 0.0017
550 SUDDEN DEATH 18 0.0017
551 CARDIO-RESPIRATORY ARREST 71 0.0017
552 BLOOD SODIUM DECREASED 32 0.0017
553 ACUTE RESPIRATORY DISTRESS SYNDROME 30 0.0017
554 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 10 0.0017
555 SUPRAVENTRICULAR TACHYCARDIA 16 0.0017
556 ADVERSE REACTION 22 0.0017
557 HEPATITIS 42 0.0016
558 HEPATIC PAIN 7 0.0016
559 HAEMORRHOIDAL HAEMORRHAGE 8 0.0016
560 RESPIRATORY DEPRESSION 20 0.0016
561 AMYLASE INCREASED 6 0.0016
562 ISCHAEMIC STROKE 29 0.0016
563 STREPTOCOCCAL INFECTION 9 0.0016
564 ACUTE RESPIRATORY FAILURE 31 0.0016
565 CLOSTRIDIUM DIFFICILE COLITIS 17 0.0016
566 FACE OEDEMA 27 0.0016
567 DEEP VEIN THROMBOSIS 104 0.0016
568 VEIN DISORDER 8 0.0016
569 BACK PAIN 371 0.0016
570 HYPOTENSION 320 0.0016
571 ASTHENIA 598 0.0016
572 UNDERDOSE 116 0.0016
573 PULMONARY EMBOLISM 151 0.0016
574 DRUG TOLERANCE 8 0.0016
575 ESCHERICHIA INFECTION 13 0.0016
576 BLOOD LACTATE DEHYDROGENASE INCREASED 25 0.0016
577 HYPERGLYCAEMIA 57 0.0016
578 ASPARTATE AMINOTRANSFERASE INCREASED 83 0.0016
579 CHILLS 183 0.0016
580 MENINGITIS ASEPTIC 7 0.0016
581 HEPATIC STEATOSIS 29 0.0016
582 PROCTALGIA 10 0.0016
583 CEREBRAL INFARCTION 38 0.0016
584 TACHYPNOEA 21 0.0015
585 SMALL INTESTINAL OBSTRUCTION 19 0.0015
586 FAILURE TO THRIVE 8 0.0015
587 BLOOD PRESSURE SYSTOLIC DECREASED 7 0.0015
588 ARTHRALGIA 637 0.0015
589 HYPOGAMMAGLOBULINAEMIA 10 0.0015
590 FISTULA 17 0.0015
591 BLOOD CALCIUM DECREASED 17 0.0015
592 ERYTHEMA MULTIFORME 14 0.0015
593 FLANK PAIN 14 0.0015
594 WEIGHT DECREASED 408 0.0015
595 HYPOVOLAEMIC SHOCK 7 0.0015
596 LARYNGEAL OEDEMA 9 0.0015
597 PIGMENTATION DISORDER 9 0.0015
598 PRODUCT USE ISSUE 273 0.0015
599 RASH PRURITIC 78 0.0014
600 FATIGUE 1110 0.0014
601 RESTLESSNESS 52 0.0014
602 DUODENAL ULCER 10 0.0014
603 PNEUMONIA 458 0.0014
604 MUSCLE SPASMS 259 0.0014
605 MALIGNANT NEOPLASM PROGRESSION 144 0.0014
606 CONSTIPATION 306 0.0014
607 TORSADE DE POINTES 11 0.0014
608 RED BLOOD CELL COUNT DECREASED 40 0.0014
609 BREAST CANCER METASTATIC 15 0.0014
610 DRUG INTERACTION 221 0.0014
611 UPPER RESPIRATORY TRACT INFECTION 64 0.0014
612 PYELONEPHRITIS 12 0.0014
613 VULVOVAGINAL PRURITUS 7 0.0014
614 RASH PUSTULAR 10 0.0014
615 URINE OUTPUT DECREASED 12 0.0014
616 HAEMATURIA 47 0.0014
617 VISUAL IMPAIRMENT 169 0.0014
618 RETCHING 29 0.0014
619 ALANINE AMINOTRANSFERASE INCREASED 83 0.0014
620 DISEASE PROGRESSION 159 0.0013
621 HYDRONEPHROSIS 10 0.0013
622 ANAL INCONTINENCE 12 0.0013
623 STATUS EPILEPTICUS 15 0.0013
624 MALAISE 579 0.0013
625 GENERALISED OEDEMA 16 0.0013
626 OLIGURIA 8 0.0013
627 BACK INJURY 14 0.0013
628 HYDROCEPHALUS 7 0.0013
629 BLOOD CREATININE INCREASED 83 0.0013
630 RESPIRATORY TRACT INFECTION 33 0.0013
631 DYSPHAGIA 120 0.0013
632 MYOCLONUS 15 0.0013
633 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 12 0.0013
634 PERITONITIS 26 0.0013
635 PERICARDIAL EFFUSION 29 0.0013
636 NEUROLOGICAL SYMPTOM 7 0.0012
637 HAEMATEMESIS 31 0.0012
638 ANXIETY 348 0.0012
639 DYSARTHRIA 46 0.0012
640 MYOCARDITIS 14 0.0012
641 SYNCOPE 122 0.0012
642 EYELID OEDEMA 14 0.0012
643 MYELOSUPPRESSION 43 0.0012
644 ATRIAL FIBRILLATION 116 0.0012
645 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 6 0.0012
646 HEMIPARESIS 20 0.0012
647 HYPERHIDROSIS 152 0.0012
648 PARAESTHESIA ORAL 17 0.0012
649 HYPERTHYROIDISM 17 0.0012
650 SHOCK 27 0.0012
651 RASH ERYTHEMATOUS 56 0.0012
652 CEREBRAL ISCHAEMIA 6 0.0012
653 BONE PAIN 68 0.0012
654 SEIZURE 134 0.0012
655 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 9 0.0012
656 METASTASES TO BONE 19 0.0012
657 PRODUCT USE IN UNAPPROVED INDICATION 286 0.0012
658 TENDERNESS 12 0.0012
659 DEPRESSION 258 0.0011
660 HYPERCALCAEMIA 14 0.0011
661 CONJUNCTIVITIS 21 0.0011
662 EATING DISORDER 24 0.0011
663 METASTASES TO LUNG 13 0.0011
664 NASAL DRYNESS 7 0.0011
665 HOSPICE CARE 11 0.0011
666 ADVERSE DRUG REACTION 100 0.0011
667 PHARYNGITIS STREPTOCOCCAL 12 0.0011
668 PAIN 677 0.0011
669 LUNG INFECTION 17 0.0011
670 COMA 52 0.0011
671 PNEUMONIA BACTERIAL 10 0.0011
672 CHOKING SENSATION 6 0.0011
673 INTESTINAL OBSTRUCTION 41 0.0011
674 OVARIAN CANCER 10 0.0011
675 MENTAL STATUS CHANGES 30 0.0011
676 HEPATITIS ACUTE 7 0.0011
677 SKIN INFECTION 12 0.0011
678 RESPIRATORY FAILURE 78 0.0011
679 CONVULSION 61 0.0011
680 APHASIA 32 0.0011
681 CIRCULATORY COLLAPSE 18 0.0011
682 EPISTAXIS 79 0.0011
683 PROTEINURIA 20 0.0011
684 TROPONIN INCREASED 8 0.0011
685 GAIT DISTURBANCE 201 0.0010
686 MENINGITIS 7 0.0010
687 PHARYNGITIS 13 0.0010
688 BACK DISORDER 17 0.0010
689 DEPRESSED LEVEL OF CONSCIOUSNESS 41 0.0010
690 GENERAL PHYSICAL CONDITION ABNORMAL 7 0.0010
691 OFF LABEL USE 897 0.0010
692 PURPURA 9 0.0010
693 PAIN IN EXTREMITY 298 0.0010
694 AUTOIMMUNE HEPATITIS 7 0.0010
695 HYPERKALAEMIA 35 0.0010
696 NEURALGIA 24 0.0010
697 HAEMOGLOBIN DECREASED 101 0.0010
698 SHOCK HAEMORRHAGIC 8 0.0010
699 BLOOD PRESSURE DECREASED 65 0.0010
700 NEOPLASM PROGRESSION 34 0.0010
701 NEUTROPHIL COUNT INCREASED 10 0.0010
702 PHARYNGEAL OEDEMA 15 0.0010
703 COUGH 273 0.0010
704 MITRAL VALVE INCOMPETENCE 11 0.0010
705 VENTRICULAR EXTRASYSTOLES 10 0.0010
706 PNEUMONIA ASPIRATION 24 0.0010
707 EOSINOPHIL COUNT INCREASED 8 0.0010
708 PALLOR 26 0.0010
709 DERMATITIS 20 0.0010
710 PRESYNCOPE 23 0.0009
711 DIZZINESS 470 0.0009
712 COLON CANCER 14 0.0009
713 CARDIAC FAILURE 75 0.0009
714 BLOOD POTASSIUM DECREASED 28 0.0009
715 CHOLECYSTITIS 11 0.0009
716 ACIDOSIS 7 0.0009
717 ASPERGILLUS INFECTION 6 0.0009
718 EOSINOPHILIA 16 0.0009
719 BACTERIAL INFECTION 17 0.0009
720 NO ADVERSE EVENT 165 0.0009
721 COLD SWEAT 16 0.0009
722 STEVENS-JOHNSON SYNDROME 20 0.0009
723 APNOEA 7 0.0009
724 ECZEMA 47 0.0009
725 GASTROINTESTINAL INFECTION 8 0.0009
726 PRODUCT PHYSICAL ISSUE 18 0.0009
727 DYSGEUSIA 66 0.0009
728 RASH GENERALISED 23 0.0009
729 LEUKOCYTOSIS 16 0.0009
730 MOTOR DYSFUNCTION 9 0.0009
731 ATRIAL FLUTTER 7 0.0009
732 IMMUNODEFICIENCY 13 0.0009
733 UTERINE CANCER 7 0.0009
734 GASTROOESOPHAGEAL REFLUX DISEASE 70 0.0009
735 BRADYCARDIA 46 0.0009
736 MELAENA 19 0.0009
737 SPLENOMEGALY 10 0.0009
738 ANOREXIA 11 0.0009
739 INCONTINENCE 9 0.0009
740 HYPOTHYROIDISM 27 0.0008
741 HAEMATOTOXICITY 8 0.0008
742 LOSS OF CONSCIOUSNESS 107 0.0008
743 UPPER GASTROINTESTINAL HAEMORRHAGE 14 0.0008
744 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 59 0.0008
745 HEADACHE 519 0.0008
746 PRODUCT PREPARATION ERROR 17 0.0008
747 PELVIC PAIN 15 0.0008
748 CLOSTRIDIUM DIFFICILE INFECTION 18 0.0008
749 GASTROENTERITIS 12 0.0008
750 THROMBOTIC MICROANGIOPATHY 8 0.0008
751 HAEMORRHOIDS 16 0.0008
752 CYTOPENIA 10 0.0008
753 HAEMATOCHEZIA 45 0.0008
754 CARDIOMEGALY 10 0.0008
755 MULTIPLE ORGAN DYSFUNCTION SYNDROME 23 0.0008
756 LOCAL SWELLING 14 0.0008
757 NEPHROPATHY TOXIC 9 0.0008
758 RENAL IMPAIRMENT 67 0.0008
759 HAEMOPTYSIS 22 0.0008
760 DYSURIA 29 0.0008
761 SKIN REACTION 11 0.0008
762 CARDIAC ARREST 64 0.0008
763 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
764 SKIN LESION 21 0.0008
765 RENAL FAILURE 101 0.0008
766 DISORIENTATION 30 0.0008
767 PRODUCTIVE COUGH 36 0.0008
768 ELECTROCARDIOGRAM QT PROLONGED 27 0.0007
769 BLOOD PRESSURE FLUCTUATION 18 0.0007
770 DIARRHOEA HAEMORRHAGIC 7 0.0007
771 OROPHARYNGEAL PAIN 68 0.0007
772 ANGINA PECTORIS 21 0.0007
773 INCREASED APPETITE 14 0.0007
774 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 52 0.0007
775 HEPATIC FAILURE 22 0.0007
776 BRONCHITIS 54 0.0007
777 INJECTION SITE EXTRAVASATION 9 0.0007
778 GASTRITIS 19 0.0007
779 URINARY RETENTION 24 0.0007
780 HEPATOMEGALY 7 0.0007
781 BODY TEMPERATURE DECREASED 7 0.0007
782 DERMATITIS CONTACT 8 0.0007
783 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 18 0.0007
784 CARDIOGENIC SHOCK 10 0.0007
785 TINNITUS 32 0.0007
786 FULL BLOOD COUNT DECREASED 14 0.0007
787 PLASMA CELL MYELOMA 27 0.0007
788 HEPATOTOXICITY 15 0.0007
789 ABDOMINAL PAIN LOWER 17 0.0007
790 CEREBRAL HAEMORRHAGE 24 0.0007
791 THROAT IRRITATION 30 0.0007
792 STAPHYLOCOCCAL INFECTION 22 0.0007
793 SINUS CONGESTION 9 0.0007
794 HYPOAESTHESIA ORAL 10 0.0007
795 TREATMENT NONCOMPLIANCE 36 0.0007
796 MUSCULOSKELETAL CHEST PAIN 10 0.0006
797 ACUTE MYOCARDIAL INFARCTION 19 0.0006
798 PRODUCT PRESCRIBING ISSUE 14 0.0006
799 URINARY INCONTINENCE 19 0.0006
800 VERTIGO 39 0.0006
801 HOT FLUSH 48 0.0006
802 VENTRICULAR FIBRILLATION 7 0.0006
803 HYPERTENSIVE CRISIS 7 0.0006
804 ABSCESS 10 0.0006
805 NECK PAIN 35 0.0006
806 HEART RATE INCREASED 62 0.0006
807 LETHARGY 36 0.0006
808 MENTAL IMPAIRMENT 15 0.0006
809 HYPOGLYCAEMIA 30 0.0006
810 DIVERTICULITIS 17 0.0006
811 PULMONARY CONGESTION 8 0.0006
812 PULMONARY MASS 9 0.0006
813 VASCULITIS 7 0.0006
814 SKIN DISORDER 20 0.0006
815 INTERNATIONAL NORMALISED RATIO INCREASED 17 0.0006
816 FLUID RETENTION 30 0.0006
817 PANCREATIC CARCINOMA 17 0.0006
818 DRUG TOXICITY 8 0.0006
819 ACUTE HEPATIC FAILURE 8 0.0006
820 CORONARY ARTERY OCCLUSION 8 0.0006
821 LYMPHOMA 9 0.0006
822 DEATH 500 0.0006
823 BLOOD URINE PRESENT 11 0.0006
824 HAEMATOMA 15 0.0006
825 GASTRIC ULCER 11 0.0006
826 ACUTE MYELOID LEUKAEMIA 9 0.0006
827 NO THERAPEUTIC RESPONSE 7 0.0006
828 MOUTH ULCERATION 12 0.0006
829 TRANSIENT ISCHAEMIC ATTACK 19 0.0006
830 AGEUSIA 14 0.0006
831 SENSORY DISTURBANCE 9 0.0006
832 THIRST 10 0.0006
833 DRUG ADMINISTRATION ERROR 17 0.0006
834 TOOTHACHE 10 0.0006
835 WRONG TECHNIQUE IN DRUG USAGE PROCESS 20 0.0005
836 ARRHYTHMIA 26 0.0005
837 MYDRIASIS 7 0.0005
838 SWOLLEN TONGUE 17 0.0005
839 DRUG LEVEL INCREASED 9 0.0005
840 ANGIOEDEMA 24 0.0005
841 DIABETIC KETOACIDOSIS 13 0.0005
842 GASTROINTESTINAL HAEMORRHAGE 45 0.0005
843 LYMPHADENOPATHY 19 0.0005
844 ABDOMINAL DISTENSION 56 0.0005
845 TUBULOINTERSTITIAL NEPHRITIS 10 0.0005
846 DYSPNOEA EXERTIONAL 20 0.0005
847 ERUCTATION 10 0.0005
848 LIVER FUNCTION TEST ABNORMAL 15 0.0005
849 HOSPITALISATION 79 0.0005
850 TREMOR 85 0.0005
851 THERAPEUTIC RESPONSE DECREASED 31 0.0005
852 LUNG NEOPLASM MALIGNANT 21 0.0005
853 PERIPHERAL COLDNESS 7 0.0005
854 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
855 PRODUCT QUALITY ISSUE 69 0.0005
856 ATAXIA 6 0.0005
857 MASS 7 0.0005
858 THROMBOSIS 40 0.0005
859 SEDATION 13 0.0005
860 BLOOD POTASSIUM INCREASED 8 0.0005
861 RASH PAPULAR 11 0.0005
862 EMOTIONAL DISTRESS 59 0.0005
863 PHOTOSENSITIVITY REACTION 8 0.0005
864 MYELODYSPLASTIC SYNDROME 7 0.0005
865 URINARY TRACT INFECTION 82 0.0005
866 PHOTOPHOBIA 9 0.0005
867 BLOOD PRESSURE INCREASED 73 0.0005
868 SWELLING FACE 31 0.0005
869 CARDIOMYOPATHY 7 0.0005
870 RESPIRATORY ARREST 13 0.0005
871 MYALGIA 80 0.0005
872 PREMATURE BABY 14 0.0005
873 LACRIMATION INCREASED 14 0.0005
874 PRURITUS GENERALISED 10 0.0005
875 BLOOD COUNT ABNORMAL 7 0.0005
876 PALPITATIONS 54 0.0005
877 ORTHOSTATIC HYPOTENSION 8 0.0005
878 SOMNOLENCE 92 0.0005
879 CELLULITIS 23 0.0005
880 RHABDOMYOLYSIS 19 0.0005
881 HYPERSOMNIA 13 0.0005
882 VISUAL ACUITY REDUCED 15 0.0005
883 RENAL DISORDER 21 0.0005
884 NEOPLASM MALIGNANT 30 0.0004
885 GOUT 8 0.0004
886 VISION BLURRED 61 0.0004
887 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 13 0.0004
888 BURNING SENSATION 31 0.0004
889 PREMATURE DELIVERY 7 0.0004
890 FEELING ABNORMAL 104 0.0004
891 MUSCLE TWITCHING 10 0.0004
892 FOETAL EXPOSURE DURING PREGNANCY 35 0.0004
893 RASH MACULAR 15 0.0004
894 DRY SKIN 57 0.0004
895 MANIA 7 0.0004
896 DIPLOPIA 11 0.0004
897 LIP SWELLING 14 0.0004
898 COAGULOPATHY 7 0.0004
899 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
900 MUSCULOSKELETAL DISCOMFORT 7 0.0004
901 TOOTH DISORDER 9 0.0004
902 PULMONARY OEDEMA 18 0.0004
903 HEAD DISCOMFORT 7 0.0004
904 PRODUCT AVAILABILITY ISSUE 9 0.0004
905 FEELING COLD 11 0.0004
906 DYSPHONIA 23 0.0004
907 BLINDNESS 16 0.0004
908 SKIN EXFOLIATION 33 0.0004
909 GASTROENTERITIS VIRAL 7 0.0004
910 HERPES ZOSTER 22 0.0004
911 BRAIN FOG 6 0.0004
912 DRUG DOSE OMISSION 63 0.0004
913 HALLUCINATION, VISUAL 8 0.0004
914 PRODUCT PRESCRIBING ERROR 9 0.0004
915 CYSTITIS 12 0.0004
916 THERAPY CESSATION 19 0.0004
917 SKIN DISCOLOURATION 17 0.0004
918 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 20 0.0004
919 OSTEONECROSIS OF JAW 9 0.0004
920 POLLAKIURIA 15 0.0004
921 COVID-19 63 0.0004
922 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
923 ACCIDENTAL OVERDOSE 13 0.0004
924 AGITATION 26 0.0004
925 PAIN IN JAW 10 0.0004
926 PSORIASIS 46 0.0004
927 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 63 0.0003
928 DEAFNESS 9 0.0003
929 OCULAR HYPERAEMIA 16 0.0003
930 PULMONARY HYPERTENSION 7 0.0003
931 CHOLELITHIASIS 11 0.0003
932 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
933 SPEECH DISORDER 17 0.0003
934 FAECES DISCOLOURED 7 0.0003
935 DEPRESSED MOOD 17 0.0003
936 INCORRECT DRUG ADMINISTRATION DURATION 9 0.0003
937 FLATULENCE 18 0.0003
938 DRUG INEFFECTIVE 417 0.0003
939 GASTRIC CANCER 8 0.0003
940 CHROMATURIA 7 0.0003
941 SKIN ULCER 8 0.0003
942 OSTEONECROSIS 10 0.0003
943 HYPOACUSIS 13 0.0003
944 CEREBROVASCULAR ACCIDENT 50 0.0003
945 RHINORRHOEA 19 0.0003
946 HEART RATE DECREASED 10 0.0003
947 INJECTION SITE ERYTHEMA 35 0.0003
948 NASAL CONGESTION 16 0.0003
949 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 14 0.0003
950 LIMB DISCOMFORT 8 0.0003
951 NERVOUS SYSTEM DISORDER 8 0.0003
952 LACTIC ACIDOSIS 8 0.0002
953 INFLUENZA 27 0.0002
954 DRY EYE 12 0.0002
955 FALL 80 0.0002
956 FUNGAL INFECTION 8 0.0002
957 NERVOUSNESS 12 0.0002
958 HALLUCINATION 17 0.0002
959 DIABETES MELLITUS 17 0.0002
960 DYSKINESIA 9 0.0002
961 MOOD SWINGS 7 0.0002
962 MOVEMENT DISORDER 7 0.0002
963 OVERDOSE 45 0.0002
964 BLOOD GLUCOSE INCREASED 39 0.0002
965 HAEMORRHAGE 21 0.0002
966 MYOCARDIAL INFARCTION 35 0.0002
967 PRODUCT DOSE OMISSION 13 0.0002
968 EYE PAIN 11 0.0002
969 INTENTIONAL PRODUCT MISUSE 17 0.0002
970 INJECTION SITE PAIN 58 0.0002
971 COLORECTAL CANCER 9 0.0002
972 EYE SWELLING 7 0.0002
973 MENTAL DISORDER 8 0.0002
974 IRRITABILITY 11 0.0002
975 SURGERY 10 0.0002
976 CATARACT 10 0.0002
977 UNEVALUABLE EVENT 12 0.0002
978 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
979 BALANCE DISORDER 13 0.0002
980 TOXICITY TO VARIOUS AGENTS 25 0.0001
981 THERAPY INTERRUPTED 10 0.0001
982 SKIN BURNING SENSATION 10 0.0001
983 CARDIAC FAILURE CONGESTIVE 11 0.0001
984 ILLNESS 14 0.0001
985 INJECTION SITE SWELLING 10 0.0001
986 BREAST CANCER 12 0.0001
987 CARDIAC DISORDER 12 0.0001
988 DEVICE MALFUNCTION 9 0.0001
989 SUICIDAL IDEATION 11 0.0001
990 PRODUCT DOSE OMISSION ISSUE 34 0.0001
991 ACNE 7 0.0001
992 INCORRECT DOSE ADMINISTERED 21 0.0001
993 DEVICE ISSUE 8 0.0001
994 CHRONIC KIDNEY DISEASE 6 0.0001
995 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001